Receptor mutation is not a common mechanism of naturally occurring glucocorticoid resistance in leukaemia cell lines
- PMID: 18789525
- DOI: 10.1016/j.leukres.2008.08.007
Receptor mutation is not a common mechanism of naturally occurring glucocorticoid resistance in leukaemia cell lines
Abstract
Glucocorticoids (GCs) are among the most important drugs for the treatment of acute lymphoblastic leukaemia (ALL). Cell lines cultured in high GC concentrations typically contain mutated glucocorticoid receptor (GR), something that is rarely found in primary ALL specimens. We studied naturally occurring mechanisms of GC resistance and examined sensitivity to GC in 15 T-ALL cell lines grown without prior exposure to drugs. Resistance could not be attributed to mutations in GR or variations in levels of its expression. We conclude that this panel of cell lines provides a suitable in vitro model since it reflects GC resistance in primary ALL.
Similar articles
-
Resistance to glucocorticoid-induced apoptosis in human T-cell acute lymphoblastic leukemia CEM-C1 cells is due to insufficient glucocorticoid receptor expression.Cancer Res. 1996 Nov 1;56(21):5033-8. Cancer Res. 1996. PMID: 8895760
-
Differential mRNA expression of glucocorticoid receptor alpha and beta is associated with glucocorticoid sensitivity of acute lymphoblastic leukemia in children.Pediatr Blood Cancer. 2005 Aug;45(2):121-7. doi: 10.1002/pbc.20308. Pediatr Blood Cancer. 2005. PMID: 15704223
-
Loss of heterozygosity and somatic mutations of the glucocorticoid receptor gene are rarely found at relapse in pediatric acute lymphoblastic leukemia but may occur in a subpopulation early in the disease course.Cancer Res. 2005 Nov 1;65(21):9712-8. doi: 10.1158/0008-5472.CAN-05-1227. Cancer Res. 2005. PMID: 16266991
-
Glucocorticoid resistance in paediatric acute lymphoblastic leukaemia.J Paediatr Child Health. 2012 Aug;48(8):634-40. doi: 10.1111/j.1440-1754.2011.02212.x. Epub 2011 Nov 3. J Paediatr Child Health. 2012. PMID: 22050419 Review.
-
Glucocorticoid receptor-mediated apoptosis: mechanisms of resistance in cancer cells.J Endocrinol. 2011 Oct;211(1):17-25. doi: 10.1530/JOE-11-0135. Epub 2011 May 20. J Endocrinol. 2011. PMID: 21602312 Review.
Cited by
-
Influence of wild-type MLL on glucocorticoid sensitivity and response to DNA-damage in pediatric acute lymphoblastic leukemia.Mol Cancer. 2010 Oct 28;9:284. doi: 10.1186/1476-4598-9-284. Mol Cancer. 2010. PMID: 20979663 Free PMC article.
-
Overcoming Glucocorticoid Resistance in Acute Lymphoblastic Leukemia: Repurposed Drugs Can Improve the Protocol.Front Oncol. 2021 Mar 11;11:617937. doi: 10.3389/fonc.2021.617937. eCollection 2021. Front Oncol. 2021. PMID: 33777761 Free PMC article. Review.
-
Combination of a selective activator of the glucocorticoid receptor Compound A with a proteasome inhibitor as a novel strategy for chemotherapy of hematologic malignancies.Cell Cycle. 2013 Jan 1;12(1):133-44. doi: 10.4161/cc.23048. Epub 2012 Dec 19. Cell Cycle. 2013. PMID: 23255118 Free PMC article.
-
GingerenoneA overcomes dexamethasone resistance by activating apoptosis and inhibiting cell proliferation in pediatric T-ALL cells.Cancer Sci. 2023 Oct;114(10):3984-3995. doi: 10.1111/cas.15936. Epub 2023 Aug 24. Cancer Sci. 2023. PMID: 37619556 Free PMC article.
-
Glucocorticoid-induced apoptosis of healthy and malignant lymphocytes.Prog Brain Res. 2010;182:1-30. doi: 10.1016/S0079-6123(10)82001-1. Prog Brain Res. 2010. PMID: 20541659 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous